A $500 annual blood testing membership promises to help consumers take their health into their own hands. Can it deliver?

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today published its 2024 Corporate Responsibility Report. Quest Diagnostics Incorporated (NYSE: DGX), a leader in ...

How much is blood work without insurance? If you don't have insurance, you'll pay the full cost for your blood work. You may want to check the costs for several labs to get the best deal. Labcorp and ...

LabCorp runs a chain of lab testing facilities in 46 states. They also sell at-home diagnostic tests. We look at their services, costs, and reputation.

After more than a year at the bargaining table, and over two months on the picket line, LifeLabs workers in BC are back at their jobs with a new collective agreement, but their union is raising the ...

This tie up resulted in an initial $570,000 order. The company also received a follow-up order of $917,000 from 400-year-old musical instrument maker Avedis Zildjian. Audeara also grew Australian ...

Quest Diagnostics Inc. DGX is investing in advanced diagnostics to deliver and scale innovative services that improve patient care and drive growth. The company’s growth strategy includes pursuing ...

SECAUCUS, N.J., June 25, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today published its 2024 Corporate Responsibility Report.

Quest will develop a blood test to detect one or more cancers, including colorectal, lung, breast, pancreatic, ovarian, liver, prostate, esophageal and stomach, based on MD Anderson technology.

Valued at a market cap of $20.1 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing, ...

ACCESS Newswire Jun 18, 2025, 6:00:00 AM Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology PR Newswire Jun 10, 2025, 5:03:00 AM ...